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A B S T R A C T
Hyperbaric oxygen (HBO) treatment was shown to be beneficial as an additional treatment for ischemic muscles in
crush injuries and ischemia-reperfusion injuries. The purpose of this study was to assess the influence of hyperbaric oxy-
gen treatment on transcriptional myogenic factors during muscle regeneration. Those factors (MyoD, myf5, myogenin,
mrf4) are essential for determination and differentiation of skeletal muscle tissue and together with several other factors
control gene expression during myogenesis. The process of regeneration in rat masseter muscle was provoked with injec-
tion of local anesthetic bupivacaine hydrochloride. Following injection, the animals were treated once daily in hyper-
baric chamber from one to ten days and than sacrificed. Immunohistochemical and Western blot analysis of frozen mass-
eter muscle samples showed a transient upregulation of myoD and myogenin transcriptional factors in the muscles of
hyperbaric oxygen treated rats and of rats that have not been treated after the injury. HBO treatment had no effect on the
expression of MyoD and myogenin transcriptional factors in the regenerating rat masseter muscle.
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Introduction
As hyperbaric oxygen (HBO) treatment was shown to
be favorable as an additional therapy for ischemic muscle
injuries1–5, various experimental models served to exam-
ine the influence of HBO on the course of muscle repair
following some other types of muscle injuries or condi-
tions6–11. Skeletal muscles consist of bundles of contrac-
tile myofibres containing hundreds of peripherally lo-
cated post-mitotic nuclei. In spite to this fact, these
organs have the capacity of plastic adaptation to func-
tional demands as well as an ability to regenerate itself
following injury. The cells responsible for providing myo-
nuclei for postnatal growth or repair are mononucleated
satellite cells. They become activated and then divide
leading to the formation of new myofibers or to repair of
existing ones. Myogenic lineage progression of satellite
cells and their myoblast progeny is regulated by various
transcriptional factors, including muscle specific basic
helix-loop-helix (bHLH) regulatory factors. The family of
bLHL myogenic factors consists of MyoD, myf5, myoge-
nin and mrf4. These factors contribute to the trans-
criptional activation of muscle genes during commitment
and differentiation of muscle fibers. They are involved in
the process of muscle regeneration either on the pro-
tein12–16 or on the transcriptional level13,17–19.
The aim of this study was to analyze the influence of
hyperbaric oxygen treatment on the expression of MyoD
and myogenin during regeneration of rat masseter
muscle.
Material and Methods
Animals and experimental procedure
Male Sprague-Dawley rats weighing 200–250 g, used
in this study, were kept in standard cages at constant
temperature and were given water and food ad libitum
throughout the experimental period. The study was ap-
proved by the Ethics Committee of the Medical Faculty of
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the University of Rijeka. The animals were anaesthe-
tized with an intraperitoneal injection of ketaminhydro-
chloride (0.1 mg/g body weight) and xylazinhydrochlo-
ride (0.02 mg/g body weight). Regeneration was induced
by injection of local anesthetic bupivacaine hydrochlo-
ride into the masseter muscle an incision overlying the
masseter muscle was done and up to 1mL of 0.5% bupi-
vacaine was injected into the superficial part of the mus-
cle. Thereafter the rats were divided in two groups: the
hyperbaric and the non-hyperbaric group. After the bupi-
vacaine hydrochloride injection, the experimental hyper-
baric group of animals underwent HBO treatment. They
were placed in hyperbaric experimental chamber in which
pure oxygen was administered at 2.2 ATA pressure in a
sixty-minute session. The sessions started on the day of
surgery and were conducted once daily. Animals were
sacrificed after 1, 2, 3, 4, 5, 7 or 10 days of treatment.
Rats in the non-hyperbaric group received no further
treatment after bupivacaine injection and were kept in
cages until they were sacrificed after 1, 2, 3, 4, 5, 7 or 10
days. The oxygen concentration in the hyperbaric cham-
ber maintained 98.5% (Dräger Oxymeter). Sodium car-
bonate crystals were used to reduce the accumulation of
CO2. All rats were killed by the ether inhalation. The
masseter muscle was removed and quickly frozen in
isopentane cooled by liquid nitrogen. The masseter mus-
cles of intact rats served as controls to the experimental
muscles, i.e. to hyperbaric and non-hyperbaric muscles.
The muscles were stored at –80°C until further analysis.
For histological analysis, serial 8 mm-thick transverse
sections were cut and stained with haematoxylin and
eosin (HE).
Protein extraction and western blotting
procedures
For MyoD and myogenin immunoblotting, the total
muscle protein containing cytoplasmatic and nuclear frac-
tions was extracted from masseter muscles by pulveriza-
tion of frozen samples. The samples were immersed in a
homogenizing buffer containing 1% Nonidet P-40, 0.5%
sodium deoxycholate, and 0.1% SDS in PBS. 0.1mM
phenylmethylsulfonylfluoride was added at the time of
use at 4°C. The samples were incubated for 30 min at 4°C.
Each homogenate was transferred to microfuge tubes
and centrifuged at 13000 rpm for 20 min at 4°C, and the
supernatant was obtained. An aliquot of the supernatant
was used to determine the protein concentration using
Bredford method, and the remainder of the supernatant
was stored at –80°C for subsequent Western blotting
analysis. Optimal loading concentration for immuno-
blotting was found to be 85 mg and 75 mg per sample for
MyoD and myogenin, respectively. To verify MyoD and
myogenin protein bands two control standards were ran
simultaneously in each gel: a molecular weight marker
(Precision Protein Standards) and protein isolated from
neonatal rat muscles (highly expressing both myogenic
regulatory factors). Proteins were denaturated by boiling
for 3 min after adding 5% solution for denaturation (500
mL Leammli, 25 mL 2-mercaptoethanol). Proteins were
separated in either a SDS-10% (MyoD) or 12.5% (myo-
genin) polyacrylamide gel. The proteins were transferred
to nitrocellulose membranes for 3 h at 70 V. The mem-
branes were immersed in blocking solution containing
0.5% nonfat dry milk (Bio-Rad), dissolved in TBS (pH
7.46), for 1 h. Then the membranes were incubated ei-
ther with the monoclonal mouse anti-MyoD (1:400) (Dako-
Cytomation) or monoclonal mouse anti-myogenin (1:400)
(DakoCytomation), diluted in blocking solution overni-
ght at 4°C. After that, the membranes were washed 6´10
min in TBS with 0.1% Tween 20 and incubated for 1 h at
room temperature with a secondary antibody (rabbit anti
mouse conjugated with peroxidase 1:2000) (DakoCyto-
mation). Then the membranes were washed 5x with TBS
with 0.1% Tween 20 for 1 h. The antibody bindings were
visualized with DAB (diaminobenzidin, 0.1 mg/mL), 0.02%
hydrogen peroxide and 0.03% CoCl. The quantity of blot-
ted proteins was evaluated by scanning densitometry.
Immunohistochemistry
For the MyoD and myogenin, the slides were fixed in
2% paraformaldehyde for 10 min, washed in TBS, and
treated with 3% H2O2 in TBS with 0.1% Tween 20
(TBST) for 5 min. Then the cryosections were washed in
TBS for 5 min. After that the slides were immersed in
blocking solution (10% normal swine serum in TBS with
0.2% bovine serum albumin – TBSTB) for 20 min. After-
wards, the slides were incubated for 60 min with the pri-
mary mouse monoclonal antibody anti-MyoD (DakoCyto-
mation) or primary mouse monoclonal antibody anti-
myogenin (DakoCytomation) diluted 1:50 in TBST. The
sections were washed 2´5 min in TBST, treated with the
secondary biotinylated antibody for 15 min and with
streptavidin conjugated to peroxidase for 15 min (LSAB+
Kit, DakoCytomation, ready-to-use). Finally, the sections
were washed in TBS, visualized with DAB for 10 min. Af-
ter rinsed in water, the sections were mounted in glycerol
gelatin medium.
Statistics
All data are expressed as means and SE. The results
within each group and between groups were compared
using a two-way analysis of variance and the Tukey-
-Kramer multiple comparisons post hoc test. The level of
significance was set at p<0.05.
Results
Histology of regenerating muscle
The first day after the bupivacaine injection, muscle
fiber degeneration and the presence of cellular infiltra-
tion was evident. On the second and third day, necrotic
muscle fibers were phagocytozed by macrophages and
during the following days, the amount of these cells de-
creased. Sporadic islets of preserved fibers were dis-
persed over the cross section. On the fourth day, small
new myofibres with central nuclei began to appear be-
coming more numerous and larger for several subse-
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quent days but ten days after injury, still remained
smaller than undamaged fibers. Space among fibers be-
came narrower (Figures 1–3).
MyoD and myogenin protein expression
MyoD and myogenin proteins were not detectable in
undamaged masseter muscles using either the Western
blot analysis or the immunohistochemical method. Their
expression was examined during sequential ten days of
the regeneration process in the masseter muscles. The
level of MyoD protein expression in regenerating mass-
eter muscle determined by Western blot analysis in-
creased on the second day. The highest level of expres-
sion was observed on the third day and than declined
towards the 5th day (Figure 4). The immunoreactive band
for myogenin protein was detected two days after injury,
on the 3rd day the level of expression was the highest and
then diminished towards the fifth day (Figure 5). There
were no significant differences in the MyoD and myo-
genin expression levels in the masseter muscles between
hyperbaric treated group and damaged but not hyper-
baric treated group.
On the second day after the regeneration was pro-
voked, MyoD positive cells, presented by the immuno-
histochemical method with anti-MyoD antibodies, be-
came visible in the regenerating regions. Day after, the
number of MyoD positive nuclei was even higher. There-
after it diminished and on the seventh day was not pres-
ent. The myogenin positive cells were observed on the
second day after bupivacaine hydrochloride injection,
and were more abundant on the third day, thereafter de-
clining. MyoD and myogenin positivity was present in
the regenerating portions, but also rare positive cells
were seen between and in undamaged fibers adjacent to
regenerating portion (Figure 6).
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Fig. 1. Cross-section of masseter muscle seven days after bupi-
vacaine injection. Small regenerating muscle fibers with central
nuclei. (H&E staining; original magnification: ´400).
Fig. 2. Cross-section of masseter muscle ten days after bupivaca-
ine injection. Small regenerating muscle fibers with central nu-
clei. (H&E staining; original magnification: ´200).
Fig. 3. Immunohistochemical staining with anti-MyoD antibod-
ies. Masseter muscle on the seventh day after bupivacaine injec-
tion. No MyoD positive nuclei. Muscle fibers in regenerating por-
tion on the left side are smaller than undamaged muscle fibers
on the right side. Original magnification: ´400.
Fig. 4. MyoD expression determined by Western blot in regenerat-
ing masseter muscle of untreated rats. The levels of MyoD pro-
tein expression in the masseter muscles after 1–5, 7 and 10 days
of regeneration. The immunoreactive band of ~45 kDa corre-
sponded to the predicted molecular mass of the rat MyoD protein.
The density of each band was expressed relative to the back-
ground density (considered to be 1.0).
Discussion and Conclusion
Our study has shown that myogenic transcriptional
factors MyoD and myogenin increased in early period of
regeneration in rat masseter muscle injected with local
anesthetic bupivacaine hydrochloride. The level of MyoD
protein expression increased on the second day, was the
highest on the third day and than declined. The myo-
genin protein was detected two days after injury, on the
3rd day the level of expression was the highest and then
diminished towards the fifth day. These results coincide
with the results of several other studies in which limb
muscles were damaged myotoxically16 or by freezing12,
although they appeared already one day after injury.
Similar results with the MyoD myogenic factor got Mc
Loon et al. in myotoxically damaged orbicularis oculi
muscle, although its expression remained increased
seven days that could be attributed to severe injury with
two doses of bupivacaine14. According to some authors,
the masseter muscle regenerate weaker than limb mus-
cles13,20. The masseter muscle displayed weaker regener-
ative response than tibialis anterior muscle when was
damaged by freeze injury; this effect might be due to
lower number of myoblasts in masseter muscle13. But the
freeze injury provokes more severe damage, while after
the bupivacaine injection satellite cells remained pre-
served and muscle regenerate rapidly21. In our study, ten
days after bupivacaine injury, histological assessment of
injured muscle has implied satisfactory process of regen-
eration.
Hyperbaric oxygen treatment improved the contrac-
tile capacity and fiber size of extensor digitorum longus
muscle8 and soleus muscle7 injured with bupivacaine in-
jection. This effect was achieved when the treatment
lasted 90 min for 25 days at 2 ATA or 14 days at 3 ATA.
As we were interested in the influence of hyperbaric oxy-
gen at the early period of myogenesis, when myogenic
regulatory factors are involved, our treatments lasted up
to ten days. The protocol applied in our study consisted
of treatments that lasted sixty minutes at 2.2 ATA pres-
sure in order to minimize possible oxidative stress, al-
though the treatment applied in their study was within
the range of values of the protocols commonly used in
clinical treatments. As exposure to hyperbaric oxygen
had mobilized stem/progenitor cells from the bone mar-
row and increased the number of circulating cells ex-
pressing CD34 and stem cell antigen-1 in mice22, we pre-
sumed that hyperbaric oxygen treatment probably could
enhance the activity of satellite cells as well, and there-
fore the expression of myogenic regulatory factors.
In conclusion, we have demonstrated that muscle re-
generation caused a transient upregulation of MyoD and
myogenin transcriptional factors in rat masseter muscle.
The role of these transcriptional regulatory factors is im-
portant in managing a regenerative response of muscle
fibers following bupivacaine hydrochloride injection. The
treatments of hyperbaric oxygenation have not altered
the expression of myoD and myogenin transcriptional
factors in damaged rat masseter muscle.
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Fig. 5. Myogenin expression determined by Western blot in regen-
erating masseter muscle of untreated rats. The levels of myoge-
nin protein expression in the masseter muscles after 1–5, 7 and
10 days of regeneration. The immunoreactive band of ~34 kDa cor-
responded to the predicted molecular mass of the rat myogenin
protein. The density of each band was expressed relative to the
background density (considered to be 1.0).
Fig. 6. Immunohistochemical demonstration of myogenin expres-
sion in cross-section of masseter muscle demonstrated on the third
day after bupivacaine injection. Note the myogenin positive nu-
clei in regenerating portion. Rare myogenin positive cells between
and in preserved muscle fibers adjacent to regenerating portion
(arrows). Original magnification: ´200.
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U^INAK TRETMANA HIPERBARI^NIM KISIKOM NA TRANSKRIPCIJSKE FAKTORE
REGENERIRAJU]EG M. MASSETER U [TAKORA
S A @ E T A K
Tretmani hiperbari~nim kisikom su se pokazali korisnima kao dodatni tretman za ishemi~ne mi{i}e u chrus-ozlje-
dama i ishemijski-reperfuzijskim ozljedama. Svrha ovog rada je bila procijeniti utjecaj tretmana hiperbari~nim kisikom
na transkripcijske miogene faktore tijekom mi{i}ne regeneracije. Ovi faktori su bitni u odre|ivanju i diferencijaciji
skeletnog mi{i}nog tkiva, te zajedno s nekoliko drugih faktora kontroliraju gensku ekspresiju tijekom miogeneze. Pro-
ces regeneracije u m. masseter {takora izazvan je injekcijom lokanog anestetika bupivakain hidroklorida. Nakon toga
su `ivotinje bile tretirane u hiperbari~noj komori jednom dnevno od jedan do deset dana i potom `rtvovane. Druga
skupina `ivotinja bila je `rtvovana u istim danima kao i prethodna skupina, ali bez tretmana hiperbari~nim kisikom.
Imunohistokemijska i Western blot analiza na smrznutim uzorcima mi{i}a pokazale su prolazno pove}anje mioD i
miogenin transkripcijskih faktora u obim skupinama `ivotinja. Tretman hiperbari~nim kisikom nije utjecao na eks-
presiju mioD i miogenin transkripcijskih faktora u regeneriraju}em mi{i}u, m.masseter, {takora.
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